These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2650274)

  • 1. The role of individual minor histocompatibility antigens in cardiac allograft rejection.
    Peugh WN; Wood KJ; Shreffler DC; Morris PJ; Morton-Bolman R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):801-2. PubMed ID: 2650274
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
    Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
    Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of sharing major histocompatibility complex and minor antigens between blood and graft donors in the blood transfusion effect.
    Peugh WN; Wood KJ; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):744-5. PubMed ID: 3274861
    [No Abstract]   [Full Text] [Related]  

  • 5. Does endotoxin accelerate rejection in a cardiac allograft model?
    Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL
    Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903
    [No Abstract]   [Full Text] [Related]  

  • 6. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic models to study cardiac allograft rejection and prolongation.
    Guttmann RD
    Transplant Proc; 1976 Mar; 8(1):31-5. PubMed ID: 769262
    [No Abstract]   [Full Text] [Related]  

  • 9. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor and class I MHC incompatibilities do not cause rejection of heart grafts but influence the rejection of skin grafts.
    Lim SM; White DJ; Calne RY
    Transplant Proc; 1987 Oct; 19(5):4229-30. PubMed ID: 3314020
    [No Abstract]   [Full Text] [Related]  

  • 13. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
    Nevala WK; Paul C; Wettstein PJ
    J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmajor histocompatibility complex genes in allograft rejection.
    Katz SM; Liebert M; Gill TJ; Kunz HW; Cramer DV
    Curr Surg; 1982; 39(6):414-7. PubMed ID: 7151479
    [No Abstract]   [Full Text] [Related]  

  • 17. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
    Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological detection of antibodies to antigens controlled by minor histocompatibility loci.
    Kano K; Kussmaul CA; Milgrom F
    Transplant Proc; 1975 Jun; 7(2):185-8. PubMed ID: 165601
    [No Abstract]   [Full Text] [Related]  

  • 19. Covert presensitization to HLA antigens in parous heart and lung transplant recipients may predispose to early allograft rejection.
    Tait BD; Dandie WJ; Griffiths AP; Esmore DS; Snell GI; Bergin P; Williams TJ
    Transplant Proc; 1995 Jun; 27(3):2143-4. PubMed ID: 7792912
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HLA antibodies and heart allograft survival.
    Fenoglio J; Ho E; Reed E; Rose E; Smith C; Reemstma K; Marboe C; Suciu-Foca N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):807-9. PubMed ID: 2650277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.